Current perspectives from clinical trials using PARP inhibitors for prostate cancer

PARP inhibitors and their evolving role for the treatment of prostate cancerПодробнее

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor...Подробнее

Role of PARP Inhibitors in Prostate CancerПодробнее

Dr. Hussain Discusses Findings With PARP Inhibitors in Prostate CancerПодробнее

Ongoing Clinical Trials with PARP Inhibitors in Ovarian CancerПодробнее

Dr. Morgan on Enrolling Patients With Prostate Cancer onto Clinical TrialsПодробнее

Clinical Trials Investigating PARP Inhibitors in Prostate CancerПодробнее

Choosing the correct PARP inhibitor for prostate cancerПодробнее

Updates in PARP Inhibition and Germline Testing in Prostate CancerПодробнее

Where can PARP inhibitors be usedПодробнее

PARP Inhibitors: Assessing the Clinical Trial LandscapeПодробнее

PARP inhibitors for metastatic hormone sensitive prostate cancerПодробнее

Comment: PARP inhibitors for advanced prostate cancerПодробнее

Combining a PARP and PD-L1 inhibitor to treat prostate cancerПодробнее

PARP inhibitors: their applications and efficacy against prostate cancerПодробнее

Targeting Advanced Prostate Cancer with PARP inhibitors: Who, When and How?Подробнее

PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathwayПодробнее

LuPARP: 177Lu-PSMA-617 and PARP inhibitor combination for prostate cancerПодробнее